Mohs Surgery, Explained: Why the Gold Standard for Skin Cancer Removal Takes All Day

The most important surgery performed in Beverly Hills dermatology offices has nothing to do with aesthetics, and almost nobody hears about it until a biopsy comes back positive. Mohs micrographic surgery is the procedure with the highest cure rate for the two most common skin cancers, basal cell carcinoma and squamous cell carcinoma, and it is performed thousands of times a year within a few miles of Rodeo Drive. Because most patients meet it for the first time under stress, this explainer covers what the procedure actually is, why it takes so long, and how to tell a careful recommendation from a reflexive one.

Why Mohs exists. Standard surgical excision removes a visible tumor plus a margin of healthy-looking skin, then sends the specimen to a lab and checks a small sample of the edges days later. The problem is that skin cancers grow like roots, with microscopic extensions invisible to the naked eye. Sample only a fraction of the margin and you can miss a root; take a very wide margin to be safe and you sacrifice healthy tissue, which matters enormously on a nose, an eyelid, or a lip. Mohs solves both problems at once. The surgeon removes the visible tumor with a thin margin, maps and freezes the tissue on site, and examines essentially one hundred percent of the surgical edge under a microscope while you wait. If any root remains, the map shows exactly where, and the surgeon removes another thin layer from only that spot. The cycle repeats until the margins are clear. According to the Skin Cancer Foundation, this technique cures up to 99 percent of basal cell carcinomas that have not been treated before, while sparing the maximum amount of healthy skin.

How the day actually goes. This is the part nobody warns you about: bring a book. Each layer takes roughly an hour to process and read, and most of that time you sit bandaged in a waiting room. Many tumors clear in one or two stages; some need three or more. The procedure runs under local anesthetic, so you are awake, you can eat, and you drive yourself home. The Mayo Clinic describes the trade honestly: the length of the day is not inefficiency, it is the price of knowing the cancer is fully out before anyone closes the wound. Compare that with conventional excision, where the definitive answer arrives from the pathology lab up to a week later and a positive margin means going back for a second operation.

Who genuinely needs it. Mohs is not the right tool for every skin cancer, and this is where an informed patient can ask a clarifying question or two. The procedure earns its keep for tumors on the face, ears, nose, lips, eyelids, scalp, hands, feet, and genitals, where tissue conservation matters most; for large tumors, recurrent tumors, tumors with aggressive growth patterns under the microscope, and cancers in patients with weakened immune systems. For a small, low-risk basal cell on the trunk or limbs, straightforward excision or other destructive methods are usually appropriate and considerably simpler, a point reflected in the appropriate use criteria that dermatology's professional societies publish. The National Cancer Institute's treatment overview lists Mohs as one option among several, matched to tumor type, location, and risk. A surgeon who explains why your specific lesion does or does not warrant Mohs is practicing medicine. One who books every biopsy-proven cancer for it by default deserves a follow-up question.

The reconstruction conversation. Clearing the cancer creates a hole, and what happens next matters as much to patients as the cure. Small defects may heal on their own or close with simple stitches. Larger ones on cosmetically sensitive sites may need flaps or grafts, performed the same day by the Mohs surgeon or coordinated with a reconstructive colleague. Ask in advance who will do the repair, what the likely options are for your tumor's location, and what the scar trajectory looks like over six to twelve months, because scars mature slowly and early appearances mislead in both directions. In this zip code there is no shortage of reconstructive skill; there is occasionally a shortage of candor about how much repair a given defect will need.

Cost, insurance, and the local wrinkle. Mohs is medical dermatology, not cosmetic, which means it generally runs through insurance the way the rest of the medical half of the specialty does, a distinction this publication mapped in cosmetic versus medical dermatology. Expect standard specialist cost-sharing rather than the cash menu. The local wrinkle is scheduling: in a market where cosmetic appointments are plentiful and medical slots are scarce, a biopsy-positive patient may be quoted a wait of weeks. Most basal cells grow slowly enough that a short wait is safe, but a rapidly growing or bleeding lesion warrants a call back asking to be seen sooner, and a squamous cell carcinoma generally moves up the queue.

How to vet the surgeon. Fellowship training matters here. Look for a board-certified dermatologist with dedicated Mohs fellowship training, ask how many cases the practice performs annually, and ask who reads the frozen sections, because in a true Mohs practice the surgeon reads their own slides, which is the entire quality loop of the technique. Ask what happens if the tumor proves deeper than expected, and where reconstruction happens if the defect outgrows the office.

The through-line. Almost every Mohs story starts the same way: a spot somebody almost ignored, caught at a routine exam. The procedure is the safety net working as designed, but the earlier net is the annual screening we detailed in our guide to full-body skin checks, and the net before that is the daily discipline of a Southern California SPF routine. Mohs is what excellent medicine looks like when prevention runs out. The goal, as ever, is to need it rarely and to recognize it when you do.

Related reading: Inside a full-body skin check.